Secukinumab Provides Sustained Improvements in the Signs and Symptoms of Active Psoriatic Arthritis: 3-Year Results from the Phase 3 Future 2 Study

Authors

P Nash
I McInnes
P Rahman
Alice B. Gottlieb, New York Medical CollegeFollow
B Kirkham
K Ding
L Pricop
Future 2 Study Grp

Author Type(s)

Faculty

Document Type

Abstract

Publication Date

6-2018

Journal Title

Annals of Rhuematic Diseases

Department

Medicine

Disciplines

Medicine and Health Sciences

Recommended Citation

Nash, P., McInnes, I., Rahman, P., Gottlieb, A. B., Kirkham, B., Ding, K., Pricop, L., & Future 2 Study Grp. (2018). Secukinumab Provides Sustained Improvements in the Signs and Symptoms of Active Psoriatic Arthritis: 3-Year Results from the Phase 3 Future 2 Study. Annals of Rhuematic Diseases, 77 (Suppl. 2), 379. Retrieved from https://touroscholar.touro.edu/nymc_fac_abstracts/377